- Key Insight: Learn why employers favor utilization tactics over structural PBM reforms despite rising specialty drug spend.
- What’s at Stake: Unsustainable specialty medication costs could erode benefits budgets and employee affordability.
- Supporting Data: 69% include pharmacy in medical plans; only 16% use pass-through PBMs.
- Source: Bullets generated by AI with editorial review
As employers head into 2026, managing pharmaceutical costs is becoming increasingly complex, driven by a convergence of rising drug prices, increased utilization of specialty medications, and continued friction within the pharmacy supply chain.
